Home
>
National Drug Code (NDC)
>
ciprofloxacin
ciprofloxacin - 50436-3135-3 - (ciprofloxacin)
Drug Information of ciprofloxacin
| Product NDC: | 50436-3135 |
| Proprietary Name: | ciprofloxacin |
| Non Proprietary Name: | ciprofloxacin |
| Active Ingredient(s): | 250 mg/1 & nbsp; ciprofloxacin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ciprofloxacin
| Product NDC: | 50436-3135 |
| Labeler Name: | Unit Dose Services |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076639 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20040910 |
Package Information of ciprofloxacin
| Package NDC: | 50436-3135-3 |
| Package Description: | 21 TABLET in 1 BOTTLE (50436-3135-3) |
NDC Information of ciprofloxacin
| NDC Code | 50436-3135-3 |
| Proprietary Name | ciprofloxacin |
| Package Description | 21 TABLET in 1 BOTTLE (50436-3135-3) |
| Product NDC | 50436-3135 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ciprofloxacin |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20040910 |
| Marketing Category Name | ANDA |
| Labeler Name | Unit Dose Services |
| Substance Name | CIPROFLOXACIN HYDROCHLORIDE |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |
